• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国西部绝经前和绝经后女性乳腺癌患者的流行病学特征、临床病理特征和治疗比较:一项回顾性多中心研究的 15389 名女性患者。

Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients.

机构信息

Department of Thyroid and Breast Surgery, The First Affiliated Hospital of ChongQing Medical University, Friendship Road, Yu-Zhong District, ChongQing, 400016, China.

Department of Oncology, The First Affiliated Hospital of ChongQing Medical University, Friendship Road, Yu-Zhong District, ChongQing, 400016, China.

出版信息

Cancer Med. 2018 Jun;7(6):2753-2763. doi: 10.1002/cam4.1503. Epub 2018 Apr 19.

DOI:10.1002/cam4.1503
PMID:29673111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6010855/
Abstract

Premenopausal and postmenopausal breast cancers are considered different types. Thus, this study aimed to explore differences in risk factors, epidemiological features, clinicopathological features, and treatment modes of premenopausal breast cancer compared to postmenopausal patients in western China. This was a hospital-based, retrospective, multicenter epidemiological study of patients with breast cancer. Using the Western China Clinical Cooperation Group database, we obtained the records of 15,389 female breast cancers between January 2010 and April 2017. These patients were divided into premenopausal and postmenopausal groups, and their risk factors, epidemiological feature, clinicopathological features, and treatment modes were compared. Chi-square tests, t-test, and the multivariate logistic regression analysis were applied for statistical analysis. A total of 8395 patients were categorized as premenopausal, and 6994 patients were categorized as postmenopausal. Their risk factors, epidemiological features, clinicopathological features, and treatment modes were compared. Premenopausal patients with breast cancer had a greater tumor diameter at diagnosis (P = 0.008); higher rates of estrogen receptor (ER) expression (P < 0.0001), progesterone receptor (PR) expression (P < 0.0001), negative human epidermal growth factor receptor 2 (HER2) expression (P = 0.015), and negative P53 expression (P < 0.0001); and higher proportions of receiving breast-conserving surgery and breast reconstruction (P < 0.0001), chemotherapy (P < 0.0001), radiotherapy (P < 0.0001), and endocrine therapy (P < 0.0001). The ethnicity, age at menarche, marital status, number of pregnancies, and number of births were the risk factors for age at diagnosis of breast cancer before or after menopause in western China. We found that the fall in the fertility rate, early menarche age, married, and less breastfeeding might have increased the possibility of premenopausal breast cancer. Significant differences exist in the tumor size, hormone receptor state, HER2 expression, epidemiological features, and treatment modes between premenopausal and postmenopausal female breast cancer patients in western China. Its further implementation requires prospective clinical testing.

摘要

绝经前和绝经后乳腺癌被认为是两种不同的类型。因此,本研究旨在探索中国西部绝经前和绝经后乳腺癌患者在危险因素、流行病学特征、临床病理特征和治疗方式方面的差异。这是一项基于医院的、回顾性的、多中心的乳腺癌患者流行病学研究。我们使用中国西部临床协作组数据库,获得了 2010 年 1 月至 2017 年 4 月期间的 15389 例女性乳腺癌患者的记录。这些患者被分为绝经前和绝经后组,并比较了她们的危险因素、流行病学特征、临床病理特征和治疗方式。应用卡方检验、t 检验和多因素 logistic 回归分析进行统计学分析。共有 8395 例患者被归类为绝经前,6994 例患者被归类为绝经后。比较了她们的危险因素、流行病学特征、临床病理特征和治疗方式。绝经前乳腺癌患者的肿瘤直径在诊断时更大(P=0.008);雌激素受体(ER)表达率更高(P<0.0001)、孕激素受体(PR)表达率更高(P<0.0001)、人表皮生长因子受体 2(HER2)阴性表达率更高(P=0.015)、P53 阴性表达率更高(P<0.0001);并且接受保乳手术和乳房重建(P<0.0001)、化疗(P<0.0001)、放疗(P<0.0001)和内分泌治疗(P<0.0001)的比例更高。在中国西部,种族、初潮年龄、婚姻状况、妊娠次数和分娩次数是绝经前和绝经后乳腺癌发病年龄的危险因素。我们发现,生育率下降、初潮年龄提前、已婚和母乳喂养较少可能增加了绝经前乳腺癌的可能性。中国西部绝经前和绝经后女性乳腺癌患者在肿瘤大小、激素受体状态、HER2 表达、流行病学特征和治疗方式方面存在显著差异。其进一步实施需要前瞻性临床测试。

相似文献

1
Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients.中国西部绝经前和绝经后女性乳腺癌患者的流行病学特征、临床病理特征和治疗比较:一项回顾性多中心研究的 15389 名女性患者。
Cancer Med. 2018 Jun;7(6):2753-2763. doi: 10.1002/cam4.1503. Epub 2018 Apr 19.
2
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.中国西部年轻(≤40岁)与年长(>40岁)女性乳腺癌患者的临床病理特征及治疗比较:一项回顾性、流行病学、多中心、仅病例研究
PLoS One. 2016 Mar 31;11(3):e0152312. doi: 10.1371/journal.pone.0152312. eCollection 2016.
3
Comparison of clinicopathological features and treatments between pre- and postmenopausal female breast cancer patients - a retrospective study.绝经前后女性乳腺癌患者临床病理特征及治疗的比较——一项回顾性研究
Prz Menopauzalny. 2019 Jun;18(2):68-73. doi: 10.5114/pm.2019.85786. Epub 2019 Jun 14.
4
Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.绝经前和绝经后乳腺癌归因于已知风险因素的比例:E3N-EPIC 队列的估计。
Int J Cancer. 2016 May 15;138(10):2415-27. doi: 10.1002/ijc.29987. Epub 2016 Feb 4.
5
Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study.上海乳腺癌研究中激素相关特征与雌激素受体/孕激素受体状态的乳腺癌风险之间的关联。
Am J Epidemiol. 2011 Sep 15;174(6):661-71. doi: 10.1093/aje/kwr145. Epub 2011 Jul 18.
6
Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.绝经前内源性甾体激素与乳腺癌风险:来自护士健康研究II的结果。
Breast Cancer Res. 2013 Mar 6;15(2):R19. doi: 10.1186/bcr3394.
7
Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.治疗绝经前亚洲女性的 HR+/HER2- 乳腺癌:亚洲乳腺癌合作组 2019 年关于卵巢抑制的共识和立场。
Breast Cancer Res Treat. 2019 Oct;177(3):549-559. doi: 10.1007/s10549-019-05318-5. Epub 2019 Jul 4.
8
Clinical characteristics of breast cancer patients in Korea in 2000.2000年韩国乳腺癌患者的临床特征
Arch Surg. 2004 Jan;139(1):27-30; discussion 31. doi: 10.1001/archsurg.139.1.27.
9
Relationship of established risk factors with breast cancer subtypes.已确立的风险因素与乳腺癌亚型的关系。
Cancer Med. 2021 Sep;10(18):6456-6467. doi: 10.1002/cam4.4158. Epub 2021 Aug 31.
10
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.雌激素受体阳性乳腺癌绝经前后女性之间孕激素受体、FOXA1、GATA3和p53的差异表达
Breast Cancer Res Treat. 2014 Apr;144(2):249-61. doi: 10.1007/s10549-014-2867-0. Epub 2014 Feb 19.

引用本文的文献

1
Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study.戈舍瑞林10.8毫克与戈舍瑞林3.6毫克相比在绝经前和围绝经期激素受体阳性乳腺癌中国患者中的真实世界疗效:一项队列研究
J Natl Cancer Cent. 2025 May 20;5(4):392-401. doi: 10.1016/j.jncc.2025.02.006. eCollection 2025 Aug.
2
Adjuvant Chemotherapy for Breast Cancer in Older Adult Patients.老年乳腺癌患者的辅助化疗。
Clin Interv Aging. 2024 Jul 16;19:1281-1286. doi: 10.2147/CIA.S470262. eCollection 2024.
3
Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study.年龄与女性乳腺癌预后呈U型关系:一项队列研究。
Front Oncol. 2023 Oct 4;13:1265304. doi: 10.3389/fonc.2023.1265304. eCollection 2023.
4
A comparative analysis of clinicopathological features and survival between pre and postmenopausal breast cancer from an Indian cohort.印度队列中绝经前和绝经后乳腺癌的临床病理特征和生存比较分析。
Sci Rep. 2023 Mar 9;13(1):3938. doi: 10.1038/s41598-023-30912-5.
5
Inclusion of premenopausal women in breast cancer clinical trials.纳入绝经前女性参加乳腺癌临床试验。
Breast. 2022 Dec;66:204-207. doi: 10.1016/j.breast.2022.10.013. Epub 2022 Oct 26.
6
A comparison of Chinese multicenter breast cancer database and SEER database.中国多中心乳腺癌数据库与 SEER 数据库的比较。
Sci Rep. 2022 Jun 21;12(1):10395. doi: 10.1038/s41598-022-14573-4.
7
Decision-making about mastectomy among Chinese women with breast cancer: a mixed-methods study protocol.决策关于乳腺癌中国女性乳房切除术:一项混合方法研究方案。
BMJ Open. 2022 Apr 20;12(4):e054685. doi: 10.1136/bmjopen-2021-054685.
8
Cost-Effectiveness Analysis from a Societal Perspective of Recurrence Index for Distant Recurrence (RecurIndex) in Women with Hormone Receptor-Positive and HER2-Negative Early-Stage Breast Cancer.从社会角度对激素受体阳性且人表皮生长因子受体2阴性的早期乳腺癌女性远处复发复发指数(RecurIndex)进行成本效益分析。
Cancer Manag Res. 2022 Feb 25;14:761-773. doi: 10.2147/CMAR.S339549. eCollection 2022.
9
Breast cancer mortality as a function of age.乳腺癌死亡率与年龄的关系。
Aging (Albany NY). 2022 Feb 8;14(3):1186-1199. doi: 10.18632/aging.203881.
10
The relationship between dietary patterns, dietary quality index, and dietary inflammatory index with the risk of all types of cancer: Golestan cohort study.饮食模式、饮食质量指数和饮食炎症指数与各类癌症风险之间的关系:戈勒斯坦队列研究
Med J Islam Repub Iran. 2021 Apr 13;35:48. doi: 10.47176/mjiri.35.48. eCollection 2021.

本文引用的文献

1
Colorectal cancer statistics, 2017.结直肠癌统计数据,2017 年。
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
2
Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients.中国乳腺癌的外科治疗:一项对18502例患者的15年单中心回顾性研究。
Medicine (Baltimore). 2016 Nov;95(45):e4201. doi: 10.1097/MD.0000000000004201.
3
Comparison of Clinicopathological Features and Treatments between Young (≤40 Years) and Older (>40 Years) Female Breast Cancer Patients in West China: A Retrospective, Epidemiological, Multicenter, Case Only Study.中国西部年轻(≤40岁)与年长(>40岁)女性乳腺癌患者的临床病理特征及治疗比较:一项回顾性、流行病学、多中心、仅病例研究
PLoS One. 2016 Mar 31;11(3):e0152312. doi: 10.1371/journal.pone.0152312. eCollection 2016.
4
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
5
How many etiological subtypes of breast cancer: two, three, four, or more?乳腺癌有多少种病因亚型:两种、三种、四种还是更多?
J Natl Cancer Inst. 2014 Aug 12;106(8). doi: 10.1093/jnci/dju165. Print 2014 Aug.
6
Breast cancer in China.中国的乳腺癌。
Lancet Oncol. 2014 Jun;15(7):e279-89. doi: 10.1016/S1470-2045(13)70567-9.
7
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.东亚某国新兴年轻女性乳腺癌的独特临床病理特征及预后:一项基于全国癌症登记处的研究
Oncologist. 2014 Jun;19(6):583-91. doi: 10.1634/theoncologist.2014-0047. Epub 2014 May 7.
8
Challenges to effective cancer control in China, India, and Russia.中国、印度和俄罗斯有效癌症控制面临的挑战。
Lancet Oncol. 2014 Apr;15(5):489-538. doi: 10.1016/S1470-2045(14)70029-4.
9
Strengthening cancer control in China.加强中国的癌症防控。
Lancet Oncol. 2014 Apr;15(5):484-5. doi: 10.1016/S1470-2045(14)70056-7.
10
Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy.中国乳腺癌和卵巢癌的归因原因:生殖因素、口服避孕药和激素替代疗法。
Chin J Cancer Res. 2012 Mar;24(1):9-17. doi: 10.1007/s11670-012-0009-y.